4-[4-(4,4,4-Trifluoro-butyl)-isoquinolin-6-yloxy]-piperidine-1-carboxylic acid tert-butyl ester → 6-(Piperidin-4-yloxy)-4-(4,4,4-trifluoro-butyl)-isoquinoline
反応式
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([O:14][C:15]2[CH:16]=[C:17]3[C:22](=[CH:23][CH:24]=2)[CH:21]=[N:20][CH:19]=[C:18]3[CH2:25][CH2:26][CH2:27][C:28]([F:31])([F:30])[F:29])[CH2:10][CH2:9]1)=O)(C)(C)C>Cl.C(O)(C)C>[NH:8]1[CH2:13][CH2:12][CH:11]([O:14][C:15]2[CH:16]=[C:17]3[C:22](=[CH:23][CH:24]=2)[CH:21]=[N:20][CH:19]=[C:18]3[CH2:25][CH2:26][CH2:27][C:28]([F:30])([F:29])[F:31])[CH2:10][CH2:9]1参加物
4
反応条件
- 温度
- 40 °C
実験手順
42 mg of compound 89 were dissolved in 5M hydrochloric acid in isopropanol. The solution was stirred at room temperature for 2 hrs and another 2 hrs at 40° C., evaporated to dryness and taken up in water and lyophilized three times to give 32 mg of the desired product as the hydrochloride salt. LCMS Method # 1, retention time 0.98 min, detected mass 338.16 [M+H]+
後処理
- customevaporated to dryness
出典と根拠
- ORDレコード
- ord-4937d72f16074d24aeb26a8bc8e48a46
- 出典データセット
- uspto-grants-2013_08
- 特許番号
- US08501736B2
反応ノート
読み込み中…